Intravitreal Ranibizumab for Choroidal Neovascularization Secondary to Gyrate Atrophy in a Young Patient: A Multimodal Imaging Analysis

Abstract

Intravitreal ranibizumab can offer promising anatomical and functional results, maintaining visual acuity in patients with CNV secondary to GA, especially if used in combination with arginine-restricted diet and vitamin B6 supplementation.